Merck | MRK - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Adidas EUR 873M 744M 2026-03
Adyen EUR 10.42B 1.99B 2025-12
Akzo Nobel EUR 1.62B 66M 2025-12
Alcon AG USD 1.58B 80M 2026-03
Amadeus IT EUR 975.6M 7.4M 2025-12
Amarin USD 131.06M 3.6M 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
BASF EUR 2.67B 811M 2025-12
Bayer EUR 6.67B 774M 2025-12
Beiersdorf EUR 1.2B 33M 2025-12
Covestro EUR 648M 44M 2025-12
Danone EUR 1.98B 364M 2025-12
Fresenius EUR 1.31B 81M 2025-12
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Genmab DKK 1.72B 46M 2025-12
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 801M 242.31M 2025-12
Henkel EUR 2.71B 163M 2025-12
Hikma Pharmaceutical USD 236M 48M 2025-06
Infineon EUR 1.3B 64M 2026-03
Lakefront Biotherapeutics EUR 66.8M 21.06M 2026-03
Linde USD 5.06B 547M 2025-12
Lonza CHF 719M 188M 2025-12
Merck EUR 2.33B 77M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Philips EUR 2.79B 882M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
UCB EUR 1.57B 1.14B 2024-12